Explore how GLP-1 medications like Ozempic can transform metabolic health and drive sustainable weight loss. Take control of your journey with expert insights and actionable strategies today.
to break down the science, applications, and implications of GLP-1 medications in a balanced and informed discussion.GLP-1 is a naturally occurring hormone that plays a significant role in regulating blood sugar and appetite. These medications, technically GLP-1 analogs, mimic the hormone's effects by enhancing insulin secretion, suppressing glucagon , and slowing gastric emptying.
Dr. Parsley traced the origins of GLP-1 therapy to observations during bariatric surgery, where researchers noticed that diabetic patients experienced rapid improvements in blood sugar regulation, even before significant weight loss occurred. This led to further investigation into gut hormones like GLP-1 and their systemic effects.One of the most evident benefits of GLP-1 medications is significant weight loss.
Conversely, he cautioned against their use in otherwise healthy individuals seeking to lose a small amount of weight. “If you’re metabolically healthy and looking to drop 10 pounds, this isn’t for you,” Dr. Parsley stated. Instead, he advocates for traditional methods like tailored nutrition and training, which are more appropriate andThey work by exploiting natural pathways in the body, but they are still pharmacological interventions with potential risks.
As always, remember that there’s no such thing as a free lunch in health or fitness, whether you’re on GLP-1s or not, the hard work of moving the dirt remains indispensable.John Welbourn is Founder/CEO of Power Athlete Inc and former NFL player. John was drafted with the 97th pick in 1999 NFL Draft and went on to be a starter for the Philadelphia Eagles from 1999-2003, appearing in 3 NFC Championship games, and started for the Kansas City Chiefs from 2004-2007.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
GLP-1 Medications Alter Thanksgiving for MillionsFor the more than 15 million U.S. adults taking Ozempic or another GLP-1 drug for diabetes or weight loss, Thanksgiving is altered. These medications reduce appetite by signaling fullness to the brain and slowing stomach emptying, leading to common side effects like nausea and constipation.
Read more »
ADA Advises Against Using Compounded GLP-1 RA MedicationsIn a new guidance statement, the American Diabetes Association advises against the use of unapproved products, warning of safety issues.
Read more »
Navigating the holidays while on weight-loss medications like Wegovy and OzempicTips for managing GLP-1 and GIP weight-loss medications during the holidays without derailing progress.
Read more »
GLP-1 RA Drug Class Benefits People With SLE, Lupus NephritisThe glucose-lowering and weight-reducing drug class appears to benefit the heart and kidneys in people with lupus and lupus nephritis, independently of glucose-lowering and weight loss.
Read more »
As GLP-1 Use Surges, Clinicians Weigh Benefits and RisksGLP-1 RAs to assist with weight loss have exploded in popularity. Researchers are working to identify which patients will benefit from them and their associated risks.
Read more »
GLP-1s Are Popular Obesity Meds, But What Role Could Prevention Play In Revamped HHS?Joshua Cohen covers healthcare policy, with a special focus on prescription drug pricing and reimbursement. Cohen writes about a wide variety of topics, including weight loss drugs, the Inflation Reduction Act, and even things like health risks related to climate change.
Read more »